世界の皮膚科OTC用医薬品市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Dermatology OTC Drug Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4114
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、117ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、皮膚科OTC用医薬品の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗真菌薬、皮膚消毒薬、皮膚刺激薬、傷や単純ヘルペス薬、乾癬治療薬、その他）、用途別市場規模（病院、ドラッグストア、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・皮膚科OTC用医薬品の市場動向
・企業の競争状況、市場シェア
・皮膚科OTC用医薬品の種類別市場規模と予測2016-2027（抗真菌薬、皮膚消毒薬、皮膚刺激薬、傷や単純ヘルペス薬、乾癬治療薬、その他）
・皮膚科OTC用医薬品の用途別市場規模と予測2016-2027（病院、ドラッグストア、その他）
・皮膚科OTC用医薬品の北米市場規模2016-2027（アメリカ、カナダ）
・皮膚科OTC用医薬品の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・皮膚科OTC用医薬品のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・皮膚科OTC用医薬品の中南米市場規模2016-2027（メキシコ、ブラジル）
・皮膚科OTC用医薬品の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Bayer、GSK、Teva、Johnson & Johnson、Novartis、Mylan、Sun Pharmaceutical、Aurobindo、Galderma、CR SANJIU、Dr. Reddy's、Lupin、Bausch Health、Cipla、Livzon、Almirall、Lingrui）
・結論

Market Analysis and Insights: Global Dermatology OTC Drug Market
The global Dermatology OTC Drug market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Dermatology OTC Drug market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Dermatology OTC Drug market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Dermatology OTC Drug market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Dermatology OTC Drug market.

Global Dermatology OTC Drug Scope and Market Size
Dermatology OTC Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Dermatology OTC Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Antifungals Medication
Skin Disinfection Medication
Skin Irritation Medication
Wounds and Herpes Simplex Medication
Anti-Psoriasis Medication
Other

Segment by Application
Hospital
Drug Store
Other

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Bayer
GSK
Teva
Johnson & Johnson
Novartis
Mylan
Sun Pharmaceutical
Aurobindo
Galderma
CR SANJIU
Dr. Reddy’s
Lupin
Bausch Health
Cipla
Livzon
Almirall
Lingrui

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Dermatology OTC Drug Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Antifungals Medication
1.2.3 Skin Disinfection Medication
1.2.4 Skin Irritation Medication
1.2.5 Wounds and Herpes Simplex Medication
1.2.6 Anti-Psoriasis Medication
1.2.7 Other
1.3 Market by Application
1.3.1 Global Dermatology OTC Drug Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Drug Store
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Dermatology OTC Drug Market Perspective (2016-2027)
2.2 Dermatology OTC Drug Growth Trends by Regions
2.2.1 Dermatology OTC Drug Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Dermatology OTC Drug Historic Market Share by Regions (2016-2021)
2.2.3 Dermatology OTC Drug Forecasted Market Size by Regions (2022-2027)
2.3 Dermatology OTC Drug Industry Dynamic
2.3.1 Dermatology OTC Drug Market Trends
2.3.2 Dermatology OTC Drug Market Drivers
2.3.3 Dermatology OTC Drug Market Challenges
2.3.4 Dermatology OTC Drug Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Dermatology OTC Drug Players by Revenue
3.1.1 Global Top Dermatology OTC Drug Players by Revenue (2016-2021)
3.1.2 Global Dermatology OTC Drug Revenue Market Share by Players (2016-2021)
3.2 Global Dermatology OTC Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Dermatology OTC Drug Revenue
3.4 Global Dermatology OTC Drug Market Concentration Ratio
3.4.1 Global Dermatology OTC Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Dermatology OTC Drug Revenue in 2020
3.5 Dermatology OTC Drug Key Players Head office and Area Served
3.6 Key Players Dermatology OTC Drug Product Solution and Service
3.7 Date of Enter into Dermatology OTC Drug Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Dermatology OTC Drug Breakdown Data by Type
4.1 Global Dermatology OTC Drug Historic Market Size by Type (2016-2021)
4.2 Global Dermatology OTC Drug Forecasted Market Size by Type (2022-2027)

5 Dermatology OTC Drug Breakdown Data by Application
5.1 Global Dermatology OTC Drug Historic Market Size by Application (2016-2021)
5.2 Global Dermatology OTC Drug Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Dermatology OTC Drug Market Size (2016-2027)
6.2 North America Dermatology OTC Drug Market Size by Type
6.2.1 North America Dermatology OTC Drug Market Size by Type (2016-2021)
6.2.2 North America Dermatology OTC Drug Market Size by Type (2022-2027)
6.2.3 North America Dermatology OTC Drug Market Size by Type (2016-2027)
6.3 North America Dermatology OTC Drug Market Size by Application
6.3.1 North America Dermatology OTC Drug Market Size by Application (2016-2021)
6.3.2 North America Dermatology OTC Drug Market Size by Application (2022-2027)
6.3.3 North America Dermatology OTC Drug Market Size by Application (2016-2027)
6.4 North America Dermatology OTC Drug Market Size by Country
6.4.1 North America Dermatology OTC Drug Market Size by Country (2016-2021)
6.4.2 North America Dermatology OTC Drug Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Dermatology OTC Drug Market Size (2016-2027)
7.2 Europe Dermatology OTC Drug Market Size by Type
7.2.1 Europe Dermatology OTC Drug Market Size by Type (2016-2021)
7.2.2 Europe Dermatology OTC Drug Market Size by Type (2022-2027)
7.2.3 Europe Dermatology OTC Drug Market Size by Type (2016-2027)
7.3 Europe Dermatology OTC Drug Market Size by Application
7.3.1 Europe Dermatology OTC Drug Market Size by Application (2016-2021)
7.3.2 Europe Dermatology OTC Drug Market Size by Application (2022-2027)
7.3.3 Europe Dermatology OTC Drug Market Size by Application (2016-2027)
7.4 Europe Dermatology OTC Drug Market Size by Country
7.4.1 Europe Dermatology OTC Drug Market Size by Country (2016-2021)
7.4.2 Europe Dermatology OTC Drug Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Dermatology OTC Drug Market Size (2016-2027)
8.2 Asia-Pacific Dermatology OTC Drug Market Size by Type
8.2.1 Asia-Pacific Dermatology OTC Drug Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Dermatology OTC Drug Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Dermatology OTC Drug Market Size by Type (2016-2027)
8.3 Asia-Pacific Dermatology OTC Drug Market Size by Application
8.3.1 Asia-Pacific Dermatology OTC Drug Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Dermatology OTC Drug Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Dermatology OTC Drug Market Size by Application (2016-2027)
8.4 Asia-Pacific Dermatology OTC Drug Market Size by Region
8.4.1 Asia-Pacific Dermatology OTC Drug Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Dermatology OTC Drug Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Dermatology OTC Drug Market Size (2016-2027)
9.2 Latin America Dermatology OTC Drug Market Size by Type
9.2.1 Latin America Dermatology OTC Drug Market Size by Type (2016-2021)
9.2.2 Latin America Dermatology OTC Drug Market Size by Type (2022-2027)
9.2.3 Latin America Dermatology OTC Drug Market Size by Type (2016-2027)
9.3 Latin America Dermatology OTC Drug Market Size by Application
9.3.1 Latin America Dermatology OTC Drug Market Size by Application (2016-2021)
9.3.2 Latin America Dermatology OTC Drug Market Size by Application (2022-2027)
9.3.3 Latin America Dermatology OTC Drug Market Size by Application (2016-2027)
9.4 Latin America Dermatology OTC Drug Market Size by Country
9.4.1 Latin America Dermatology OTC Drug Market Size by Country (2016-2021)
9.4.2 Latin America Dermatology OTC Drug Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Dermatology OTC Drug Market Size (2016-2027)
10.2 Middle East & Africa Dermatology OTC Drug Market Size by Type
10.2.1 Middle East & Africa Dermatology OTC Drug Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Dermatology OTC Drug Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Dermatology OTC Drug Market Size by Type (2016-2027)
10.3 Middle East & Africa Dermatology OTC Drug Market Size by Application
10.3.1 Middle East & Africa Dermatology OTC Drug Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Dermatology OTC Drug Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Dermatology OTC Drug Market Size by Application (2016-2027)
10.4 Middle East & Africa Dermatology OTC Drug Market Size by Country
10.4.1 Middle East & Africa Dermatology OTC Drug Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Dermatology OTC Drug Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Bayer
11.1.1 Bayer Company Details
11.1.2 Bayer Business Overview
11.1.3 Bayer Dermatology OTC Drug Introduction
11.1.4 Bayer Revenue in Dermatology OTC Drug Business (2016-2021)
11.1.5 Bayer Recent Development
11.2 GSK
11.2.1 GSK Company Details
11.2.2 GSK Business Overview
11.2.3 GSK Dermatology OTC Drug Introduction
11.2.4 GSK Revenue in Dermatology OTC Drug Business (2016-2021)
11.2.5 GSK Recent Development
11.3 Teva
11.3.1 Teva Company Details
11.3.2 Teva Business Overview
11.3.3 Teva Dermatology OTC Drug Introduction
11.3.4 Teva Revenue in Dermatology OTC Drug Business (2016-2021)
11.3.5 Teva Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Details
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Dermatology OTC Drug Introduction
11.4.4 Johnson & Johnson Revenue in Dermatology OTC Drug Business (2016-2021)
11.4.5 Johnson & Johnson Recent Development
11.5 Novartis
11.5.1 Novartis Company Details
11.5.2 Novartis Business Overview
11.5.3 Novartis Dermatology OTC Drug Introduction
11.5.4 Novartis Revenue in Dermatology OTC Drug Business (2016-2021)
11.5.5 Novartis Recent Development
11.6 Mylan
11.6.1 Mylan Company Details
11.6.2 Mylan Business Overview
11.6.3 Mylan Dermatology OTC Drug Introduction
11.6.4 Mylan Revenue in Dermatology OTC Drug Business (2016-2021)
11.6.5 Mylan Recent Development
11.7 Sun Pharmaceutical
11.7.1 Sun Pharmaceutical Company Details
11.7.2 Sun Pharmaceutical Business Overview
11.7.3 Sun Pharmaceutical Dermatology OTC Drug Introduction
11.7.4 Sun Pharmaceutical Revenue in Dermatology OTC Drug Business (2016-2021)
11.7.5 Sun Pharmaceutical Recent Development
11.8 Aurobindo
11.8.1 Aurobindo Company Details
11.8.2 Aurobindo Business Overview
11.8.3 Aurobindo Dermatology OTC Drug Introduction
11.8.4 Aurobindo Revenue in Dermatology OTC Drug Business (2016-2021)
11.8.5 Aurobindo Recent Development
11.9 Galderma
11.9.1 Galderma Company Details
11.9.2 Galderma Business Overview
11.9.3 Galderma Dermatology OTC Drug Introduction
11.9.4 Galderma Revenue in Dermatology OTC Drug Business (2016-2021)
11.9.5 Galderma Recent Development
11.10 CR SANJIU
11.10.1 CR SANJIU Company Details
11.10.2 CR SANJIU Business Overview
11.10.3 CR SANJIU Dermatology OTC Drug Introduction
11.10.4 CR SANJIU Revenue in Dermatology OTC Drug Business (2016-2021)
11.10.5 CR SANJIU Recent Development
11.11 Dr. Reddy’s
11.11.1 Dr. Reddy’s Company Details
11.11.2 Dr. Reddy’s Business Overview
11.11.3 Dr. Reddy’s Dermatology OTC Drug Introduction
11.11.4 Dr. Reddy’s Revenue in Dermatology OTC Drug Business (2016-2021)
11.11.5 Dr. Reddy’s Recent Development
11.12 Lupin
11.12.1 Lupin Company Details
11.12.2 Lupin Business Overview
11.12.3 Lupin Dermatology OTC Drug Introduction
11.12.4 Lupin Revenue in Dermatology OTC Drug Business (2016-2021)
11.12.5 Lupin Recent Development
11.13 Bausch Health
11.13.1 Bausch Health Company Details
11.13.2 Bausch Health Business Overview
11.13.3 Bausch Health Dermatology OTC Drug Introduction
11.13.4 Bausch Health Revenue in Dermatology OTC Drug Business (2016-2021)
11.13.5 Bausch Health Recent Development
11.14 Cipla
11.14.1 Cipla Company Details
11.14.2 Cipla Business Overview
11.14.3 Cipla Dermatology OTC Drug Introduction
11.14.4 Cipla Revenue in Dermatology OTC Drug Business (2016-2021)
11.14.5 Cipla Recent Development
11.15 Livzon
11.15.1 Livzon Company Details
11.15.2 Livzon Business Overview
11.15.3 Livzon Dermatology OTC Drug Introduction
11.15.4 Livzon Revenue in Dermatology OTC Drug Business (2016-2021)
11.15.5 Livzon Recent Development
11.16 Almirall
11.16.1 Almirall Company Details
11.16.2 Almirall Business Overview
11.16.3 Almirall Dermatology OTC Drug Introduction
11.16.4 Almirall Revenue in Dermatology OTC Drug Business (2016-2021)
11.16.5 Almirall Recent Development
11.17 Lingrui
11.17.1 Lingrui Company Details
11.17.2 Lingrui Business Overview
11.17.3 Lingrui Dermatology OTC Drug Introduction
11.17.4 Lingrui Revenue in Dermatology OTC Drug Business (2016-2021)
11.17.5 Lingrui Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Dermatology OTC Drug Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Antifungals Medication
Table 3. Key Players of Skin Disinfection Medication
Table 4. Key Players of Skin Irritation Medication
Table 5. Key Players of Wounds and Herpes Simplex Medication
Table 6. Key Players of Anti-Psoriasis Medication
Table 7. Key Players of Other
Table 8. Global Dermatology OTC Drug Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Dermatology OTC Drug Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Dermatology OTC Drug Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global Dermatology OTC Drug Market Share by Regions (2016-2021)
Table 12. Global Dermatology OTC Drug Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global Dermatology OTC Drug Market Share by Regions (2022-2027)
Table 14. Dermatology OTC Drug Market Trends
Table 15. Dermatology OTC Drug Market Drivers
Table 16. Dermatology OTC Drug Market Challenges
Table 17. Dermatology OTC Drug Market Restraints
Table 18. Global Dermatology OTC Drug Revenue by Players (2016-2021) & (US$ Million)
Table 19. Global Dermatology OTC Drug Market Share by Players (2016-2021)
Table 20. Global Top Dermatology OTC Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dermatology OTC Drug as of 2020)
Table 21. Ranking of Global Top Dermatology OTC Drug Companies by Revenue (US$ Million) in 2020
Table 22. Global 5 Largest Players Market Share by Dermatology OTC Drug Revenue (CR5 and HHI) & (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Dermatology OTC Drug Product Solution and Service
Table 25. Date of Enter into Dermatology OTC Drug Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Dermatology OTC Drug Market Size by Type (2016-2021) (US$ Million)
Table 28. Global Dermatology OTC Drug Revenue Market Share by Type (2016-2021)
Table 29. Global Dermatology OTC Drug Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 30. Global Dermatology OTC Drug Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 31. Global Dermatology OTC Drug Market Size Share by Application (2016-2021) & (US$ Million)
Table 32. Global Dermatology OTC Drug Revenue Market Share by Application (2016-2021)
Table 33. Global Dermatology OTC Drug Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 34. Global Dermatology OTC Drug Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 35. North America Dermatology OTC Drug Market Size by Type (2016-2021) (US$ Million)
Table 36. North America Dermatology OTC Drug Market Size by Type (2022-2027) & (US$ Million)
Table 37. North America Dermatology OTC Drug Market Size by Application (2016-2021) (US$ Million)
Table 38. North America Dermatology OTC Drug Market Size by Application (2022-2027) & (US$ Million)
Table 39. North America Dermatology OTC Drug Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America Dermatology OTC Drug Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe Dermatology OTC Drug Market Size by Type (2016-2021) (US$ Million)
Table 42. Europe Dermatology OTC Drug Market Size by Type (2022-2027) & (US$ Million)
Table 43. Europe Dermatology OTC Drug Market Size by Application (2016-2021) (US$ Million)
Table 44. Europe Dermatology OTC Drug Market Size by Application (2022-2027) & (US$ Million)
Table 45. Europe Dermatology OTC Drug Market Size by Country (2016-2021) & (US$ Million)
Table 46. Europe Dermatology OTC Drug Market Size by Country (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Dermatology OTC Drug Market Size by Type (2016-2021) (US$ Million)
Table 48. Asia-Pacific Dermatology OTC Drug Market Size by Type (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Dermatology OTC Drug Market Size by Application (2016-2021) (US$ Million)
Table 50. Asia-Pacific Dermatology OTC Drug Market Size by Application (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Dermatology OTC Drug Market Size by Region (2016-2021) & (US$ Million)
Table 52. Asia-Pacific Dermatology OTC Drug Market Size by Region (2022-2027) & (US$ Million)
Table 53. Latin America Dermatology OTC Drug Market Size by Type (2016-2021) (US$ Million)
Table 54. Latin America Dermatology OTC Drug Market Size by Type (2022-2027) & (US$ Million)
Table 55. Latin America Dermatology OTC Drug Market Size by Application (2016-2021) (US$ Million)
Table 56. Latin America Dermatology OTC Drug Market Size by Application (2022-2027) & (US$ Million)
Table 57. Latin America Dermatology OTC Drug Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America Dermatology OTC Drug Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Dermatology OTC Drug Market Size by Type (2016-2021) (US$ Million)
Table 60. Middle East & Africa Dermatology OTC Drug Market Size by Type (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Dermatology OTC Drug Market Size by Application (2016-2021) (US$ Million)
Table 62. Middle East & Africa Dermatology OTC Drug Market Size by Application (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Dermatology OTC Drug Market Size by Country (2016-2021) & (US$ Million)
Table 64. Middle East & Africa Dermatology OTC Drug Market Size by Country (2022-2027) & (US$ Million)
Table 65. Bayer Company Details
Table 66. Bayer Business Overview
Table 67. Bayer Dermatology OTC Drug Product
Table 68. Bayer Revenue in Dermatology OTC Drug Business (2016-2021) & (US$ Million)
Table 69. Bayer Recent Development
Table 70. GSK Company Details
Table 71. GSK Business Overview
Table 72. GSK Dermatology OTC Drug Product
Table 73. GSK Revenue in Dermatology OTC Drug Business (2016-2021) & (US$ Million)
Table 74. GSK Recent Development
Table 75. Teva Company Details
Table 76. Teva Business Overview
Table 77. Teva Dermatology OTC Drug Product
Table 78. Teva Revenue in Dermatology OTC Drug Business (2016-2021) & (US$ Million)
Table 79. Teva Recent Development
Table 80. Johnson & Johnson Company Details
Table 81. Johnson & Johnson Business Overview
Table 82. Johnson & Johnson Dermatology OTC Drug Product
Table 83. Johnson & Johnson Revenue in Dermatology OTC Drug Business (2016-2021) & (US$ Million)
Table 84. Johnson & Johnson Recent Development
Table 85. Novartis Company Details
Table 86. Novartis Business Overview
Table 87. Novartis Dermatology OTC Drug Product
Table 88. Novartis Revenue in Dermatology OTC Drug Business (2016-2021) & (US$ Million)
Table 89. Novartis Recent Development
Table 90. Mylan Company Details
Table 91. Mylan Business Overview
Table 92. Mylan Dermatology OTC Drug Product
Table 93. Mylan Revenue in Dermatology OTC Drug Business (2016-2021) & (US$ Million)
Table 94. Mylan Recent Development
Table 95. Sun Pharmaceutical Company Details
Table 96. Sun Pharmaceutical Business Overview
Table 97. Sun Pharmaceutical Dermatology OTC Drug Product
Table 98. Sun Pharmaceutical Revenue in Dermatology OTC Drug Business (2016-2021) & (US$ Million)
Table 99. Sun Pharmaceutical Recent Development
Table 100. Aurobindo Company Details
Table 101. Aurobindo Business Overview
Table 102. Aurobindo Revenue in Dermatology OTC Drug Business (2016-2021) & (US$ Million)
Table 103. Aurobindo Recent Development
Table 104. Galderma Company Details
Table 105. Galderma Business Overview
Table 106. Galderma Dermatology OTC Drug Product
Table 107. Galderma Revenue in Dermatology OTC Drug Business (2016-2021) & (US$ Million)
Table 108. Galderma Recent Development
Table 109. CR SANJIU Company Details
Table 110. CR SANJIU Business Overview
Table 111. CR SANJIU Dermatology OTC Drug Product
Table 112. CR SANJIU Revenue in Dermatology OTC Drug Business (2016-2021) & (US$ Million)
Table 113. CR SANJIU Recent Development
Table 114. Dr. Reddy's Company Details
Table 115. Dr. Reddy's Business Overview
Table 116. Dr. Reddy's Dermatology OTC Drug Product
Table 117. Dr. Reddy's Revenue in Dermatology OTC Drug Business (2016-2021) & (US$ Million)
Table 118. Dr. Reddy's Recent Development
Table 119. Lupin Company Details
Table 120. Lupin Business Overview
Table 121. Lupin Dermatology OTC Drug Product
Table 122. Lupin Revenue in Dermatology OTC Drug Business (2016-2021) & (US$ Million)
Table 123. Lupin Recent Development
Table 124. Bausch Health Company Details
Table 125. Bausch Health Business Overview
Table 126. Bausch Health Dermatology OTC Drug Product
Table 127. Bausch Health Revenue in Dermatology OTC Drug Business (2016-2021) & (US$ Million)
Table 128. Bausch Health Recent Development
Table 129. Cipla Company Details
Table 130. Cipla Business Overview
Table 131. Cipla Dermatology OTC Drug Product
Table 132. Cipla Revenue in Dermatology OTC Drug Business (2016-2021) & (US$ Million)
Table 133. Cipla Recent Development
Table 134. Livzon Company Details
Table 135. Livzon Business Overview
Table 136. Livzon Dermatology OTC Drug Product
Table 137. Livzon Revenue in Dermatology OTC Drug Business (2016-2021) & (US$ Million)
Table 138. Livzon Recent Development
Table 139. Almirall Company Details
Table 140. Almirall Business Overview
Table 141. Almirall Dermatology OTC Drug Product
Table 142. Almirall Revenue in Dermatology OTC Drug Business (2016-2021) & (US$ Million)
Table 143. Almirall Recent Development
Table 144. Lingrui Company Details
Table 145. Lingrui Business Overview
Table 146. Lingrui Dermatology OTC Drug Product
Table 147. Lingrui Revenue in Dermatology OTC Drug Business (2016-2021) & (US$ Million)
Table 148. Lingrui Recent Development
Table 149. Research Programs/Design for This Report
Table 150. Key Data Information from Secondary Sources
Table 151. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Dermatology OTC Drug Market Share by Type: 2020 VS 2027
Figure 2. Antifungals Medication Features
Figure 3. Skin Disinfection Medication Features
Figure 4. Skin Irritation Medication Features
Figure 5. Wounds and Herpes Simplex Medication Features
Figure 6. Anti-Psoriasis Medication Features
Figure 7. Other Features
Figure 8. Global Dermatology OTC Drug Market Share by Application: 2020 VS 2027
Figure 9. Hospital Case Studies
Figure 10. Drug Store Case Studies
Figure 11. Other Case Studies
Figure 12. Dermatology OTC Drug Report Years Considered
Figure 13. Global Dermatology OTC Drug Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Dermatology OTC Drug Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Dermatology OTC Drug Market Share by Regions: 2020 VS 2027
Figure 16. Global Dermatology OTC Drug Market Share by Regions (2022-2027)
Figure 17. Global Dermatology OTC Drug Market Share by Players in 2020
Figure 18. Global Top Dermatology OTC Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dermatology OTC Drug as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Dermatology OTC Drug Revenue in 2020
Figure 20. Global Dermatology OTC Drug Revenue Market Share by Type (2016-2021)
Figure 21. Global Dermatology OTC Drug Revenue Market Share by Type (2022-2027)
Figure 22. North America Dermatology OTC Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Dermatology OTC Drug Market Share by Type (2016-2027)
Figure 24. North America Dermatology OTC Drug Market Share by Application (2016-2027)
Figure 25. North America Dermatology OTC Drug Market Share by Country (2016-2027)
Figure 26. United States Dermatology OTC Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Dermatology OTC Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Dermatology OTC Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Dermatology OTC Drug Market Share by Type (2016-2027)
Figure 30. Europe Dermatology OTC Drug Market Share by Application (2016-2027)
Figure 31. Europe Dermatology OTC Drug Market Share by Country (2016-2027)
Figure 32. Germany Dermatology OTC Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Dermatology OTC Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Dermatology OTC Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Dermatology OTC Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Dermatology OTC Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Dermatology OTC Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Dermatology OTC Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Dermatology OTC Drug Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Dermatology OTC Drug Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Dermatology OTC Drug Market Share by Region (2016-2027)
Figure 42. China Dermatology OTC Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Dermatology OTC Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Dermatology OTC Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Dermatology OTC Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Dermatology OTC Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Dermatology OTC Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Dermatology OTC Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Dermatology OTC Drug Market Share by Type (2016-2027)
Figure 50. Latin America Dermatology OTC Drug Market Share by Application (2016-2027)
Figure 51. Latin America Dermatology OTC Drug Market Share by Country (2016-2027)
Figure 52. Mexico Dermatology OTC Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Dermatology OTC Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Dermatology OTC Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Dermatology OTC Drug Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Dermatology OTC Drug Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Dermatology OTC Drug Market Share by Country (2016-2027)
Figure 58. Turkey Dermatology OTC Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Dermatology OTC Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Dermatology OTC Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Bayer Revenue Growth Rate in Dermatology OTC Drug Business (2016-2021)
Figure 62. GSK Revenue Growth Rate in Dermatology OTC Drug Business (2016-2021)
Figure 63. Teva Revenue Growth Rate in Dermatology OTC Drug Business (2016-2021)
Figure 64. Johnson & Johnson Revenue Growth Rate in Dermatology OTC Drug Business (2016-2021)
Figure 65. Novartis Revenue Growth Rate in Dermatology OTC Drug Business (2016-2021)
Figure 66. Mylan Revenue Growth Rate in Dermatology OTC Drug Business (2016-2021)
Figure 67. Sun Pharmaceutical Revenue Growth Rate in Dermatology OTC Drug Business (2016-2021)
Figure 68. Aurobindo Revenue Growth Rate in Dermatology OTC Drug Business (2016-2021)
Figure 69. Galderma Revenue Growth Rate in Dermatology OTC Drug Business (2016-2021)
Figure 70. CR SANJIU Revenue Growth Rate in Dermatology OTC Drug Business (2016-2021)
Figure 71. Dr. Reddy's Revenue Growth Rate in Dermatology OTC Drug Business (2016-2021)
Figure 72. Lupin Revenue Growth Rate in Dermatology OTC Drug Business (2016-2021)
Figure 73. Bausch Health Revenue Growth Rate in Dermatology OTC Drug Business (2016-2021)
Figure 74. Cipla Revenue Growth Rate in Dermatology OTC Drug Business (2016-2021)
Figure 75. Livzon Revenue Growth Rate in Dermatology OTC Drug Business (2016-2021)
Figure 76. Almirall Revenue Growth Rate in Dermatology OTC Drug Business (2016-2021)
Figure 77. Lingrui Revenue Growth Rate in Dermatology OTC Drug Business (2016-2021)
Figure 78. Bottom-up and Top-down Approaches for This Report
Figure 79. Data Triangulation
Figure 80. Key Executives Interviewed

以下、関連資料のご紹介

世界の皮膚科におけるオゾン療法市場規模・現状・予測（2021年-2027年）

Global Ozone Therapy in Dermatology Market Size, Status and Forecast 2021-2027
QFJ1-4642 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、皮膚科におけるオゾン療法の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（オゾン発生器、オゾン注射器、皮膚科オゾン療法機、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、...

世界の皮膚科医療用レーザー市場規模・現状・予測（2021年-2027年）

Global Dermatology Medical Lasers Market Size, Status and Forecast 2021-2027
QFJ1-4113 2021年6月 105Pages
QYResearch社発行の本調査レポートでは、皮膚科医療用レーザーの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（外科用レーザー、血管用レーザー）、用途別市場規模（ガン、脱毛、タトゥー除去、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジ...

世界の皮膚科処方薬市場規模・現状・予測（2021年-2027年）

Global Prescription Dermatology Therapeutics Market Size, Status and Forecast 2021-2027
QFJ1-4760 2021年6月 108Pages
QYResearch社発行の本調査レポートでは、皮膚科処方薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（真菌感染症薬、皮膚がん薬、にきび＆酒皶薬、乾癬薬、皮膚炎＆脂漏症薬）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規...

世界のスニチニブ薬市場規模・現状・予測（2021年-2027年）

Global Sunitinib Drug Market Size, Status and Forecast 2021-2027
QFJ1-6026 2021年6月 89Pages
QYResearch社発行の本調査レポートでは、スニチニブ薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（12.5mgカプセル、25mgカプセル、37.5mgカプセル、50mgカプセル）、用途別市場規模（腎臓がん、GIST、pNET）、主要地域別...

世界の甲状腺機能低下症治療薬市場規模・現状・予測（2021年-2027年）

Global Hypothyroidism Drug Market Size, Status and Forecast 2021-2027
QFJ1-4342 2021年6月 87Pages
QYResearch社発行の本調査レポートでは、甲状腺機能低下症治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（BCT-305、GX-30、レボチロキシンナトリウムSR、リオチロニン、その他）、用途別市場規模（病院、診療所、その他）、主要地域...

世界のアンブリセンタン薬市場規模・現状・予測（2021年-2027年）

Global Ambrisentan Drug Market Size, Status and Forecast 2021-2027
QFJ1-5574 2021年6月 87Pages
QYResearch社発行の本調査レポートでは、アンブリセンタン薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（5mg錠、10mg錠）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南...

世界の抗コリン薬市場規模・現状・予測（2021年-2027年）

Global Anticholinergic Drug Market Size, Status and Forecast 2021-2027
QFJ1-5583 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、抗コリン薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口、非経口、局所）、用途別市場規模（病院薬局、小売薬局、オンライン薬局、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中...

世界の向精神薬市場規模・現状・予測（2021年-2027年）

Global Psychotropic Drug Market Size, Status and Forecast 2021-2027
QFJ1-4785 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、向精神薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（鎮痛薬、麻酔薬、催眠薬、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、...

世界のパルボシクリブ薬市場規模・現状・予測（2021年-2027年）

Global Palbociclib Drug Market Size, Status and Forecast 2021-2027
QFJ1-5925 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、パルボシクリブ薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（錠剤タイプパルボシクリブ薬、カプセルタイプパルボシクリブ薬）、用途別市場規模（病院、診断センター、研究所）、主要地域別市場規模（北米、ア...

世界のノイラミニダーゼ阻害薬市場規模・現状・予測（2021年-2027年）

Global Neuraminidase Inhibitors Drug Market Size, Status and Forecast 2021-2027
QFJ1-5878 2021年6月 86Pages
QYResearch社発行の本調査レポートでは、ノイラミニダーゼ阻害薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（オセルタミビル、ザナミビル、ペラミビル、ラニナミビル）、用途別市場規模（病院薬局、小売薬局、オンライン薬局、その他）、主要地域別市...

世界の抗糖尿病薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Anti-diabetic Medication Market The global Anti-diabetic Medication market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the …
世界の歯科用医薬品市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Medication for Dental Market The global Medication for Dental market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report…
世界のCOPD用治療薬市場規模・現状・予測（2021年-2027年） Chronic obstructive pulmonary disease (COPD) is a chronic inflammatory lung disease that causes obstructed airflow from the lungs. Symptoms include breathing difficulty, cough, mucus (sputum) production and wheezing. It's typically caused by long-term exposure to irritating gases or particulate matt…
世界の注射式鎮痛薬市場規模・現状・予測（2021年-2027年） Analgesics refer to drugs that can partially or completely relieve pain. There are two types of non-steroidal anti-inflammatory drugs and central analgesics. The latter is currently mainly used in the treatment of cancer pain, and can also be used for short-term postoperative pain relief. Market Ana…
世界の投薬＆包装システム市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Medication Dispensing and Packaging Systems Market The global Medication Dispensing and Packaging Systems market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in …